Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvant

• Gen Li,
• Meixing Yu,
• Qiong Ke,
• Jing Sun,
• Yanwen Peng,
• Chuanfeng Xiong,
• Olivia Monteiro,
• COVID-19 Infection and Immunity Investigation Group,
• Jincun Zhao,
• Andy P. Xiang

Affiliations

Gen Li

Guangzhou Women and Children’s Medical Center, Guangzhou Medical University

Meixing Yu

Guangzhou Women and Children’s Medical Center, Guangzhou Medical University

Qiong Ke

Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University

Jing Sun

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital, Guangzhou Medical University

Yanwen Peng

Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University

Chuanfeng Xiong

Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University

Olivia Monteiro

Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology

COVID-19 Infection and Immunity Investigation Group

Jincun Zhao

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital, Guangzhou Medical University

Andy P. Xiang

Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University